Effects of hormone replacement therapy on plaque stability, inflammation, and fibrinolysis in hypertensive or overweight postmenopausal women

American Journal of Cardiology

Volumn 88, Issue 12, 2001, Pages 1423-1426

  Kon Koh, Kwang ^a,b   Ahn, Jeong Yeal ^b   Kang, Moon Ho ^c   Kim, Dae Sung ^c   Jin, Dong Kyu ^a   Sohn, Min Soo ^a   Park, Gi Soo ^a   Choi, In Suck ^a   Shin, Eak Kyun ^a  

^a Cardiology   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c Endocrinology and Metabolism   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GELATINASE B; GESTAGEN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGESTERONE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LABORATORY TEST; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS;

CORONARY ARTERIOSCLEROSIS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOLYSIS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTENSION; INFLAMMATION; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OBESITY; POSTMENOPAUSE;

EID: 0035893271     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02126-9     Document Type: Article

References (20)

1. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study
2. Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia and hyperinsulinemia
3. Obesity: Impact on cardiovascular disease
4. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - The evidence report
5. Guidelines for the management of hypertension
6. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women
7. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women
8. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women
9. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial
10. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages
11. 2+ mobilization
12. ENOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity
13. Effects of statins on vascular wall: Vasomotor function, inflammation, and plaque stability
14. Effects of HMG-CoA reductase inhibitor on hemostasis
15. Estrogen modulation of JE/monocygte chemoattractant protein-1 mRNA expression in murine macrophages
16. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD
17. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
18. Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the factor V Leiden mutation (resistance to activated protein C)
19. Effects of hormone replacement therapy on coagulation and fibrinolysis in postmenopausal women
20. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause